A federal appeals court has dealt a blow to Novartis’ attempt to apply the sharp limits on punitive damages claims of its home state New Jersey to litigation over its cancer drugs Aredia and Zometa.
On Thursday in Winter v. Novartis Pharmaceuticals, the U.S. Court of Appeals for the Eighth Circuit rejected the company’s request for a new trial on that jurisdictional issue. The ruling affirmed Western District of Missouri U.S. District Judge Nanette Laughrey’s application of Missouri law to those claims.
